anti-MAPKAP1 antibody product blogThe MAPKAP1 n/a (Catalog #MBS6001494) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The MAPKAP1, CT (MAPKAP1, MIP1, SIN1, Target of rapamycin complex 2 subunit MAPKAP1, Mitogen-activated protein kinase 2-associated protein 1, Stress-activated map kinase-interacting protein 1) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s MAPKAP1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in Western Blot, ELISA
Dilution: ELISA: 1:1,000
Western Blot: 1:100-500. Researchers should empirically determine the suitability of the MAPKAP1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MAPKAP1, CT (MAPKAP1, MIP1, SIN1, Target of rapamycin complex 2 subunit MAPKAP1, Mitogen-activated protein kinase 2-associated protein 1, Stress-activated map kinase-interacting protein 1)
This gene encodes a protein that is highly similar to the yeast SIN1 protein, a stress-activated protein kinase. Alternatively spliced transcript variants encoding distinct isoforms have been described. Alternate polyadenylation sites as well as alternate 3\' UTRs have been identified for transcripts of this gene.
Immunogen: MAPKAP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 480-510 amino acids from the C-terminal region of human MAPKAP1. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MAPKAP1 are readily searchable from our website. Different antibodies against the same target such as MAPKAP1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.